RE: CDX news soon?1 Oct 2021 10:47
I think you mis understand the discussion.
I suggest Eli will buy HEMO out down the line. That’s my view. At the appropriate time of course.
Another point is the deal getting done on CDX to secure the IP from GlobalCo going forward so work can continue and in my view see Globalco continue to work with HEMO in some capacity on it. This whole transaction helps to validate HEMO tech if the collab effectively continues into clinical trials.
The SP moved from 9p+ down to 2p for a combo of reasons including CLNs and a ‘no option taken’ RNS re CDX and GlobalCo.
For them to formally officially throw their hat back in the ring, possibly with an Eli Lilly name drop, extending our collab on CDX into clinical trials and therefore extending the potential (and likelihood) of then wanting to buy a successful CDX down the line, I think it is you under estimates the potential content of any milestone and it’s context for HEMO.
I hope they’ll include things like using their labs and scientists to run the trials as a point that may be in the ‘deal’. We shall see.
If you think there have been six months negotiations solely about whether GlobalCo want £1m or £1.5m for their IP i respectively suggest you need to do more research.